Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-04
The reference study identifies excessive calpain activation as a mechanistic link between maternal non-obstetric surgery during pregnancy and later cognitive impairment in rat offspring. Its rescue experiments connect calpain activity to disrupted hippocampal BDNF/TrkB signaling, synaptic structure, and behavior, providing a framework for studying protease-dependent neurodevelopmental injury.
-
α-KG, LKB1–AMPK, and HPDLSC Senescence
2026-09-04
This 2026 Cellular Signalling study identifies an α-ketoglutarate/LKB1–AMPK axis that links mitochondrial recovery with reduced inflammation-induced senescence in human periodontal ligament stem cells. Its combined cell and animal evidence suggests that restoring mitochondrial homeostasis may improve osteogenic competence and periodontal regeneration, while also defining important boundaries for translation to other experimental systems.
-
ABT-199 Workflow for Mitochondrial Apoptosis
2026-09-03
ABT-199 (Venetoclax) provides a selective way to test BCL-2 dependence in hematologic cancer models while limiting BCL-XL-associated confounding. This practical workflow combines dose-response analysis, orthogonal apoptosis readouts, and transcription-aware controls inspired by recent Pol II degradation research.
-
CCT007093: A Practical PPM1D Inhibitor Workflow
2026-09-03
CCT007093 is a DMSO-soluble PPM1D inhibitor for linking phosphatase activity to P38 MAPK signaling, pyroptosis, and cell viability. This workflow separates early pathway activation from later cytotoxicity and adapts the compound for kidney-injury and breast-cancer research.
-
Cepharanthine Workflows for Endometriosis Research
2026-09-02
Build a translational Cepharanthine workflow that progresses from stromal-cell viability and apoptosis research to patient-derived endometrial organoids and murine lesions. The approach combines formulation control, mechanism-resolved readouts, and troubleshooting designed to separate disease-relevant activity from nonspecific toxicity.
-
LY-411575: Notch-to-Tumor Immune Assays
2026-09-02
LY-411575 is a highly potent gamma-secretase inhibitor for dissecting amyloid beta production and Notch biology. This article connects its biochemical activity to tumor-immune assay design, using recent TNBC findings to explain why timing, compartment, and immune readouts matter.
-
Palomid 529: A Precision Lens on ESCC Resistance
2026-09-01
Palomid 529 (P529) offers a dual mTORC1/mTORC2 approach for investigating PI3K/Akt/mTOR signaling in esophageal squamous cell carcinoma. This article focuses on assay design, causal interpretation, and how to connect RCN2-driven cisplatin resistance with tumor angiogenesis inhibition and radiotherapy enhancement.
-
Ro 3306 for Reliable Cell-Cycle Assays
2026-09-01
Learn how Ro 3306, SKU A8885, can improve interpretation of cell-cycle, proliferation, viability, and DNA-repair experiments. This scenario-based guide covers mechanism, solvent handling, G2/M synchronization, assay controls, data interpretation, and practical product selection.
-
Reactive Oxygen Species Assay Kit: Mechanism
2026-08-31
Explore how the Reactive Oxygen Species Assay Kit (DHE) converts intracellular superoxide into a mechanistically useful endpoint. This guide connects DHE fluorescence with the PINK1–Parkin mitophagy findings reported in pulmonary fibrosis research and explains how to interpret the assay rigorously.
-
FKBP9, ER Stress, and Glioblastoma Malignancy
2026-08-31
Xu et al. identify FKBP9 as an ER-resident immunophilin that promotes glioblastoma growth, invasion, and tumor formation while protecting cells from ER stress. The study connects FKBP9 to ASK1–p38MAPK signaling and the IRE1α–XBP1 unfolded protein response, providing a mechanistic framework for studying stress-adapted GBM biology.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-30
Song and colleagues show that murine norovirus exploits the membrane-rupture protein NINJ1 to release the viral immunomodulatory protein NS1 through an unconventional, caspase-3-dependent pathway. The study combines CRISPR screening, infection models, protein-interaction analysis, mutagenesis, and mouse experiments to connect selective viral secretion with enteric infection.
-
IEM-1925 Against Soman-Induced Status Epilepticus
2026-08-29
A 2026 NeuroToxicology study examined IEM-1925 as a dual AMPA/NMDA glutamate receptor strategy for soman-induced status epilepticus, reporting coordinated seizure suppression, hippocampal protection, and improved behavioral outcomes in rats. Its main contribution is to connect acute electrographic seizure control with longer-term neurodegeneration and cognition endpoints, while highlighting limitations of transient benzodiazepine-based control.
-
Panobinostat (LBH589): An ECM–Immune Assay Lens
2026-08-28
Panobinostat (LBH589) offers a powerful way to connect HDAC-dependent epigenetic regulation with macrophage–fibroblast extracellular-matrix remodeling. This article translates recent form-deprivation myopia findings into a rigorous assay framework while distinguishing pharmacological pathway effects from cell-type-specific causality.
-
10058-F4: Practical c-Myc-Max Inhibition Workflows
2026-08-28
10058-F4 enables time-controlled disruption of c-Myc/Max signaling in apoptosis assays, acute myeloid leukemia research, and prostate cancer models. This guide connects compound handling with target-engagement readouts, experimental controls, and a cautious extension toward APEX2–TERT studies.
-
ECM Internalisation, p38β, and Cancer Cell Migration
2026-08-27
Martinez et al. developed a live-cell, high-content assay that revealed extracellular matrix internalisation as an active regulator of invasive carcinoma-cell migration. Their data connect α2β1 integrin, MAP3K1, MAPK11/p38β, PPP2R1A, and NHE1 to ECM uptake and lysosomal processing, creating a mechanistic framework for studying tumour invasion and pathway-directed experiments.